Skip to main content
Springer logoLink to Springer
. 2025 Dec 24;43(2):917. doi: 10.1007/s12325-025-03464-5

Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial

Kyoko Kikuno 1,, Ryuta Asada 2, Takuma Ishihara 3, Ken-ichirou Morishige 4, Kenro Chikazawa 5, Tatsuro Furui 1, Masanori Isobe 1
PMCID: PMC12909403  PMID: 41442031

Correction to: Adv Ther 10.1007/s12325-025-03397-z

In the originally published version of this article, the mean reduction in serum estradiol (E2) levels for the 1 mg group was incorrectly printed as “− 0.45 pg/mL (95% CI: − 152.51 to −  28.39)”. The correct value is “− 90.45 pg/mL (95% CI: − 152.51 to − 28.39)”.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Advances in Therapy are provided here courtesy of Springer

RESOURCES